The first coronavirus vaccine to roll out is being made by Pfizer and BioNTech and takes a new approach to protecting you from infection by using what is called messenger RNA or mRNA. Unlike a ...
Last year, the High Court ruled that one of Moderna’s patents relating to the messenger RNA (mRNA) technology, which underpinned its COVID-19 vaccine, was valid and that Pfizer and BioNTech’s ...
Pfizer/BioNTech has initiated its application to the US Food and Drug Administration for full FDA approval of its Covid-19 vaccine for people ages 16 and older, the companies said Friday. This is the ...
The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains 1 Shipping of the LP.8.1-adapted vaccine will ...
LONDON (Reuters) -Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed one of Moderna's patents at London's Court of Appeal. Last ...
Hosted on MSN
Pfizer and BioNTech’s New Vaccine Study: A Potential Game-Changer for COVID-19 Prevention
Pfizer Inc ((PFE)), Biontech Se Sponsored Adr ((BNTX)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. DAKAR, Senegal (AP) — Senegal and Rwanda ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback